No Data
Fuan Pharmaceutical (300194.SZ): Cefoperazone sodium for injection passes the consistency evaluation of generic drug quality and efficacy.
On August 2, Gelonhui reported that Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Qingyutang Pharmaceutical Co., Ltd. (hereinafter referred to as 'Qingyutang'), recently received a notification of drug supplementary application approval issued by the National Medical Products Administration of China. After examination, injection of cephalosporin sodium passed the consistency evaluation of generic drug quality and efficacy. Cephalosporin sodium for injection is an anti-infective drug mainly used for lower respiratory tract infection, urinary tract infection, abdominal infection, pelvic infection, sepsis, soft tissue infection, bone and joint infection, pneumococcal or influenza bacteraemia, and meningitis.
As of July 31, the number of shareholders for Fuan Pharmaceutical (300194.SZ) was 40,774.
Fuan Pharmaceutical (300194.SZ) stated on the investor interaction platform on August 1 that as of July 31, the number of shareholders in the company was 40,774.
Fuan Pharmaceutical's Unit Gets Registration Certificate for Voriconazole for Injection
Fuan Pharmaceutical (300194.SZ): Zhichu Pharmaceutical has received the registration certificate of injection Voriconazole.
On July 24th, Gelunhui reported that Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Yantai Zhichu Pharmaceutical Co., Ltd. (referred to as 'Zhichu Pharmaceutical'), recently received a drug registration certificate issued by the National Medical Products Administration for injection of fluconazole. Injection of fluconazole is a broad-spectrum triazole antifungal drug, mainly used to treat fungal infections in adults and children aged 2 and above. According to the China National Medical Products Administration data query information platform, as of now, 18 enterprises (including Zhichu Pharmaceutical) have passed consistency evaluation or been deemed as equivalent.
As of July 20th, the number of shareholders of Fuan Pharmaceutical (300194.SZ) was 40,466.
Fuan Pharmaceutical (300194.SZ) stated on the investor interaction platform on July 23 that as of July 20, the number of shareholders of the company was 40,466.
Fuan Pharmaceutical: 2024 Interim Performance Forecast
Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Looks Inexpensive After Falling 26% But Perhaps Not Attractive EnoughNo Data
